Insider trading allegations at Gland Pharma
A company associated with the management is said to have divested a 4% stake when it likely had access to unpublished price-sensitive information.
Subscribe to read this story
We publish over 500 original, detailed stories every year on startups, corporates, stock markets and economic current affairs.
$99 for one year
Not ready to subscribe? Sign up for a free account
We value our free readers. Read 100+ stories every year.
More in Business
You may also like
India’s listed SME space is a ticking time bomb
If recent investigations by SEBI into cases of fraud by listed SMEs are any indication, a scam running into lakhs of crores is in the making, putting the entire financial system at risk.
Decoding SEBI’s new skin-in-the-game regulations for AMCs
While paying heed to the growing concerns of mutual funds around how mandatory investment norms are affecting junior employees, the market regulator has ensured the industry remains accountable to investors.
Why quick delivery of medicines will be difficult to scale
Quick-commerce apps are likely to run into regulations and poor order volumes as they try to grow this business.